| Literature DB >> 23943720 |
Parthasarathy D Thirumala1, Santhosh Kumar Mohanraj, Miguel Habeych, Kelley Wichman, Yue-Fang Chang, Paul Gardner, Carl Snyderman, Donald J Crammond, Jeffrey Balzer.
Abstract
Objective To evaluate the value of free-run electromyography (f-EMG) monitoring of extraocular cranial nerves (EOCN) III, IV, and VI during expanded endonasal surgery (EES) of the skull base in reducing iatrogenic cranial nerve (CN) deficits. Design We retrospectively identified 200 patients out of 990 who had at least one EOCN monitored during EES. We further separated patients into groups according to the specific CN monitored. In each CN group, we classified patients who had significant (SG) f-EMG activity as Group I and those who did not as Group II. Results A total of 696 EOCNs were monitored. The number of muscles supplied by EOCNs that had SG f-EMG activity was 88, including CN III = 46, CN IV = 21, and CN VI = 21. There were two deficits involving CN VI in patients who had SG f-EMG activity during surgery. There were 14 deficits observed, including CN III = 3, CN IV = 2, and CN VI = 9 in patients who did not have SG f-EMG activity during surgery. Conclusions f-EMG monitoring of EOCN during EES can be useful in identifying the location of the nerve. It seems to have limited value in predicting postoperative neurological deficits. Future studies to evaluate the EMG of EOCN during EES need to be done with both f-EMG and triggered EMG.Entities:
Keywords: electromyography; expanded endonasal surgery; lower cranial nerves
Year: 2013 PMID: 23943720 PMCID: PMC3713562 DOI: 10.1055/s-0033-1346975
Source DB: PubMed Journal: J Neurol Surg Rep ISSN: 2193-6358
Demographic and Patient Data of Monitored Patients
| Number of patients monitored | 200 | 100% |
|---|---|---|
| Male | 88 | 44% |
| Female | 112 | 56% |
| Transellar | 51 | 26% |
| Transclival | 91 | 46% |
| Transplanum | 13 | 6.50% |
| Transcavernous | 12 | 6.00% |
| Transpterygoidal | 12 | 6.00% |
| Others | 21 | 10.50% |
| 2000-2005 | 50 | 25% |
| 2006-2008 | 150 | 75% |
| Meningioma | 43 | 22% |
| Chordoma | 25 | 13% |
| Pituitary tumor | 37 | 18.50% |
| Chondrosarcoma | 6 | 3.00% |
| Angiofibroma | 12 | 6.00% |
| Others | 77 | 37.50% |
Data Indicating the Cranial Nerve Monitored and Postoperative Outcome
| Cranial nerves | III | IV | VI | V | VII | IX | X | XI | XII | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total number of patients monitored | 153 | 135 | 187 | 16 | 39 | 32 | 35 | 14 | 32 | |
| Total number of nerves monitored | 219 | 192 | 285 | 24 | 63 | 55 | 61 | 24 | 59 | |
| Right | 43 | 40 | 41 | 3 | 9 | 5 | 5 | 2 | 2 | |
| Left | 44 | 38 | 48 | 5 | 6 | 4 | 4 | 2 | 3 | |
| Both | 66 | 57 | 98 | 8 | 24 | 23 | 26 | 10 | 27 | |
| 39 | 20 | 18 | 1 | 10 | 6 | 6 | 2 | 2 | ||
| Number of cranial nerves with significant activity | 46 | 21 | 21 | 1 | 15 | 8 | 10 | 4 | 3 | |
| Total cranial nerve deficits in patients with significant activity | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Transient | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Permanent | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 114 | 115 | 169 | 15 | 29 | 26 | 29 | 12 | 30 | ||
| Number of cranial nerves without significant activity | 173 | 171 | 264 | 23 | 48 | 47 | 53 | 20 | 56 | |
| Total cranial nerve deficits in patients without significant activity | 3 | 2 | 9 | 0 | 0 | 1 | 1 | 0 | 1 | |
| Transient | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Permanent | 3 | 1 | 7 | 0 | 0 | 1 | 1 | 0 | 1 |
Clinical Extraocular Cranial Nerve Deficits in Individual Patients
| Patient # | Age | Sex | Diagnosis | Surgery | CN monitored | Side monitored | Nerve deficit |
|---|---|---|---|---|---|---|---|
| 1 | 62 | Male | Clival chordoma | Transclival | VI | Bilateral | VI left |
| 2 | 69 | Female | Meningioma | Transclival | VI | Right | VI right |
| 3 | 34 | Female | Meningioma | Transclival | VI | Bilateral | VI right |
| 4 | 48 | Female | Pituitary adenoma | Transellar | VI | Bilateral | VI bilateral |
| 5 | 64 | Female | Pituitary adenoma | Transcavernous | IV&VI | Right side in both | IV & VI right in both |
| 6 | 22 | Male | Pituitary adenoma | Transclival Transellar-zone 4 | VI | Right | VI right |
| 7 | 13 | Male | Angiofibroma | Transpterygoidal | VI | Bilateral | VI right |
| 8 | 13 | Male | Angiofibroma | Transpterygoidal | IV | Bilateral | IV left |
| 9 | 66 | Male | Pituitary adenoma | Transellar | III | Left | III left |
| 10 | 58 | Female | Pituitary adenoma | Transellar | III | Right | III right |
| 11 | 53 | Male | Pituitary adenoma | Transclival, Transplanum- Transclival | VI | Bilateral | VI left |
| 12 | 30 | Female | Pituitary adenoma | Transellar | VI | Right | VI right |
| 13 | 59 | Female | Pituitary adenoma | Transcavernous | III&VI | Bilateral in both | III &VI right in both |
Abbreviation: CN, cranial nerve.
Data Show Incidence of Free-run Electromyographic Activity in the Extraocular Cranial Nerve
| Cranial nerve | III | IV | VI |
|---|---|---|---|
| Number of patients monitored | 153 | 135 | 187 |
| Number of nerves monitored | 219 | 192 | 285 |
| Number of nerves with significant activity | 46 | 21 | 21 |
| Incidence of significant activity | 21% | 11% | 7% |
| Mean and standard deviation for EMG alerts per nerve | 3.4 ± 3.08 | 2.10 ± 1.49 | 2.22 ± 1.59 |
| Median and range for EMG alerts per nerve | 3 (1-14) | 1 (1-6) | 2 (1-6) |
| Free-run EMG activity observed in patients with CN deficits | 0 | 0 | 2 |
Abbreviations: CN, cranial nerve; EMG, electromyelography.
Statistical Analysis of Different Variables in Cranial Nerve III
| Cranial nerve III | ||||||
|---|---|---|---|---|---|---|
| SG = no | SG = yes | |||||
| 51 | 71.83 | 20 | 28.17 | |||
| 59 | 74.68 | 20 | 25.32 | 0.693 | ||
| 85 | 72.03 | 33 | 27.97 | |||
| 24 | 77.42 | 7 | 22.58 | 0.547 | ||
| 38 | 65.52 | 20 | 34.48 | |||
| 36 | 75.00 | 12 | 25.00 | |||
| 36 | 81.82 | 8 | 18.18 | 0.174 | ||
| 17 | 68.00 | 8 | 32.00 | |||
| 93 | 74.40 | 32 | 25.60 | 0.509 | ||
| 170 | 78.70 | 46 | 21.30 | |||
| 3 | 100 | 0 | 0.00 | 1.000 | ||
| 51.21 | 17.88 | 44.91 | 16.79 | 0.055 | ||
Abbreviations: ND, neurological deficit; SD, standard deviation; SG, significant activity.
Statistical Analysis of Different Variables in Cranial Nerve IV
| Cranial nerve IV | ||||||
|---|---|---|---|---|---|---|
| SG = no | SG = yes | |||||
| 54 | 87.10 | 8 | 12.90 | |||
| 52 | 81.25 | 12 | 18.75 | 0.369 | ||
| 83 | 84.69 | 15 | 15.31 | |||
| 22 | 81.48 | 5 | 18.52 | 0.768 | ||
| 37 | 77.08 | 11 | 22.92 | |||
| 39 | 90.70 | 4 | 9.30 | |||
| 30 | 85.71 | 5 | 14.29 | 0.198 | ||
| 14 | 82.35 | 3 | 17.65 | |||
| 92 | 84.40 | 17 | 15.60 | 0.733 | ||
| 169 | 88.95 | 21 | 11.05 | |||
| 2 | 100.00 | 0 | 0.00 | 1.000 | ||
| 48.34 | 17.28 | 49.25 | 21.56 | 0.835 | ||
Abbreviations: ND, neurological deficit; SD, standard deviation; SG, significant activity.
Statistical Analysis of Different Variables in Cranial Nerve VI
| Cranial Nerve VI | ||||||
|---|---|---|---|---|---|---|
| SG = no | SG = yes | |||||
| 78 | 91.76 | 7 | 8.24 | |||
| 89 | 89.90 | 10 | 10.10 | 0.663 | ||
| 126 | 91.30 | 12 | 8.70 | |||
| 40 | 88.89 | 5 | 11.11 | 0.570 | ||
| 76 | 88.37 | 10 | 11.63 | |||
| 46 | 95.83 | 2 | 4.17 | |||
| 45 | 90.00 | 5 | 10.00 | 0.411 | ||
| 29 | 82.86 | 6 | 17.14 | |||
| 138 | 92.62 | 11 | 7.38 | 0.100 | ||
| 255 | 93.07 | 19 | 6.93 | |||
| 9 | 81.82 | 2 | 18.18 | 0.190 | ||
| 47.75 | 18.82 | 43.09 | 17.70 | 0.329 | ||
Abbreviations: ND, neurological deficit; SD, standard deviation; SG, significant activity.